These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Peripheral vasomotor drugs]. BRUCKE F. Wien Med Wochenschr; 1956 Nov 10; 106(45):931-2. PubMed ID: 13401751 [No Abstract] [Full Text] [Related]
23. [On the use of vasoactive drugs]. Cortinovis A, Cortinovis R, Pellegrino L. Chir Patol Sper; 1968 Nov 10; ():Suppl 5:156+. PubMed ID: 5743361 [No Abstract] [Full Text] [Related]
24. [Therapeutic control of the path of the blood flow of the end organs]. Gersmeyer EF, Leicht E. Med Welt; 1967 Feb 25; 8():426-31. PubMed ID: 6044562 [No Abstract] [Full Text] [Related]
25. [Internal therapy of varicose syndrome with vasotonin]. SCHWEITZER GG. Ther Ggw; 1953 Dec 25; 92(12):456-7. PubMed ID: 13136097 [No Abstract] [Full Text] [Related]
26. A clinical and laboratory comparison of the effects of commonly used vasodilator drugs on arterial diseases. STALLWORTH JM, LEE WH, BELISLE C, NUNN DB. Am Surg; 1958 Oct 25; 24(10):700-8. PubMed ID: 13583455 [No Abstract] [Full Text] [Related]
27. [Pharmacology of peripheral sympathomimetics & the conclusions drawn from it for the treatment of shock & collapse]. SCHNEIDER KW. Dtsch Med J; 1958 May 25; 9(5):236-9. PubMed ID: 13547916 [No Abstract] [Full Text] [Related]
28. [Treatment of chronic obliterating arteritis: importance of a combination of vasodilator products]. LENG-LEVY J, DAVID-CHAUSSE J, SERRES A, LABORIE G, VEAUX R. J Med Bord; 1957 Oct 25; 134(10):1218-24. PubMed ID: 13481517 [No Abstract] [Full Text] [Related]
29. Vasopressor and vasodilator drugs in the treatment of shock. Bradley EC, Weil MH. Mod Treat; 1967 Mar 25; 4(2):243-55. PubMed ID: 5592030 [No Abstract] [Full Text] [Related]
30. [Hydrocortisone-vasoconstrictor drug combination in treatment of acute rhinitis]. BARBET J. Gaz Med Fr; 1956 Nov 25; 63(22):1925-6; passim. PubMed ID: 13397724 [No Abstract] [Full Text] [Related]
31. [Modifications of urinary hydroxyproline by therapeutic measures with vascular effects (apropos of 25 cases)]. Recordier AM, Serratrice G, Eisinger J, Valente P, Ragnoni R. Rhumatologie; 1967 Nov 25; 19(6):223-5. PubMed ID: 5610757 [No Abstract] [Full Text] [Related]
33. [Experimental and therapeutic experiences with intra-arterial injections in peripheral circulatory disorders]. OKOS G, SAS V. Orv Hetil; 1953 Mar 29; 94(13):352-6. PubMed ID: 13063965 [No Abstract] [Full Text] [Related]
34. [Evaluation of the use of vascular agents in massive acute hemorrhage]. Uvarov BS, Gel'd VG. Eksp Khir Anesteziol; 1973 Mar 29; 18(3):56-8. PubMed ID: 4149335 [No Abstract] [Full Text] [Related]
35. [Place of pharmacodynamic agents in the treatment of the state of shock]. Charlier P. Coeur Med Interne; 1969 Jul 29; 8(3):363-90. PubMed ID: 5398958 [No Abstract] [Full Text] [Related]
36. [Treatment of coronary insufficiency with persantin]. TETZLAFF H, TETZLAFF D. Med Monatsschr; 1959 Apr 29; 13(4):229-31. PubMed ID: 13656374 [No Abstract] [Full Text] [Related]
38. Effects of vasoconstrictors used in local anesthetics in patients with diseases of the heart. SALMAN I, SCHWARTZ SP. J Oral Surg (Chic); 1955 Jul 29; 13(3):209-13. PubMed ID: 14392539 [No Abstract] [Full Text] [Related]
39. A new drug and technique in the treatment of chronic helomata. SHAFRITZ S. J Natl Assoc Chirop; 1954 Mar 29; 44(3):45-7. PubMed ID: 13143398 [No Abstract] [Full Text] [Related]
40. Prophylaxis and treatment of acute renal failure by vasoactive agents: the fact and the myths. Conger J. Kidney Int Suppl; 1998 Feb 29; 64():S23-6. PubMed ID: 9475484 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]